ADOBE INC. ⋅ 10-Q ⋅ 6/15 Canopy Growth Corp ⋅ 10-K ⋅ 6/15 COMTECH TELECOMMUNICATIONS CORP /DE/ ⋅ 10-Q ⋅ 6/15 Coda Octopus Group, Inc. ⋅ 10-Q ⋅ 6/15 Quantumsphere Acquisition Corp ⋅ 10-K ⋅ 6/15 enGene Therapeutics Inc. ⋅ 10-Q ⋅ 6/15 Helio Corp /FL/ ⋅ 10-Q ⋅ 6/15 HAMMER TECHNOLOGY HOLDINGS CORP. ⋅ 10-Q ⋅ 6/15 Glidelogic Corp. ⋅ 10-Q ⋅ 6/15 AUTOZONE INC ⋅ 10-Q ⋅ 6/12

ADOBE INC. ⋅ 10-Q ⋅ 6/15 Canopy Growth Corp ⋅ 10-K ⋅ 6/15 COMTECH TELECOMMUNICATIONS CORP /DE/ ⋅ 10-Q ⋅ 6/15 Coda Octopus Group, Inc. ⋅ 10-Q ⋅ 6/15 Quantumsphere Acquisition Corp ⋅ 10-K ⋅ 6/15 enGene Therapeutics Inc. ⋅ 10-Q ⋅ 6/15 Helio Corp /FL/ ⋅ 10-Q ⋅ 6/15 HAMMER TECHNOLOGY HOLDINGS CORP. ⋅ 10-Q ⋅ 6/15 Glidelogic Corp. ⋅ 10-Q ⋅ 6/15 AUTOZONE INC ⋅ 10-Q ⋅ 6/12

enGene Therapeutics Inc.

Biological Products, (No Diagnostic Substances) | SIC: 2836
Phone: (514) 332-4888

CIK: 0001980845
State of Inc.: Z4

Tickers:

Nasdaq:ENGN
Nasdaq:ENGNW

Business Address:
4868 RUE LEVY, SUITE 220
SAINT-LAURENT,

Mailing Address:
4868 RUE LEVY, SUITE 220
SAINT-LAURENT,

Former Names:

14 Jun 2023 to 09 Mar 2026 | enGene Holdings Inc.

Last 10-Q filed 15 Jun 2026 | Documents: 82
Next Earnings: 12 Sep 2026